Refocus Group, Inc. Our mission is to revolutionize the way presbyopia is treated, and we are committed to providing effective solutions for patients. Our groundbreaking product, the VisAbility™ Micro Insert System, is currently undergoing clinical trials in the United States.

It is the world's first binocular presbyopic treatment that operates outside of the visual axis. By utilizing this innovative system, we aim to help patients reduce or completely eliminate their reliance on reading glasses. At Refocus Group, we prioritize the advancement of vision care, and our leadership team is comprised of experienced professionals dedicated to driving our mission forward.

We are constantly seeking talented individuals to join our team and contribute to our innovative research and development efforts. For more information about our company, mission, and leadership team, please explore the links provided. Contact us today to learn more about our groundbreaking treatments and how we can help improve your vision